Lucence Patents – Insights & Stats

Lucence has a total of 30 patents globally, out of which 3 have been granted. Of these 30 patents, more than 90% patents are active. Singapore is where Lucence has filed the maximum number of patents, followed by the USA and Europe. Parallelly, Singapore seems to be the main focused R&D center and also USA is the origin country of Lucence.

Lucence was founded in 2016 Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients with life-changing information.

Do read about some of the most popular patents of Lucence which have been covered by us in this article and also you can find Lucence patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over the Lucence patent portfolio.

How many patents does Lucence have?

Lucence has a total of 30 patents globally. These patents belong to 13 unique patent families. Out of 30 patents, 27 patents are active.

How Many Patents did Lucence File Every Year?

Lucence Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLucence Applications FiledLucence Patents Granted
20144
20169
20181
201941
202031
202191

How many Lucence patents are Alive/Dead?

Worldwide Patents

Lucence Patents Portfolio

How Many Patents did Lucence File in Different Countries?

Lucence Worldwide Patents

Countries in which Lucence Filed Patents

CountryPatents
Singapore8
United States Of America5
Europe4
Germany3
Hong Kong (S.A.R.)3
Malaysia1

Where are Research Centers of Lucence Patents Located?

Research Centers of Lucence Patents

List of Lucence Patents –

Publication NumberTitle
US20180073083A1A Multigene Assay
US20160230234A1Multigene Assay For Prognosis Of Renal Cancer
US20220117587A1Method Of Sample Collection
US20210180125A1Method For The Detection And Quantification Of Genetic Alterations
US20190085417A1Detection And Quantification Of Target Nucleic Acid Sequence Of A Microorganism
EP3268495A1A Multigene Assay
EP3047040A1Multigene Assay For Prognosis Of Renal Cancer
EP3390672A1Detection And Quantification Of Target Nucleic Acid Sequence Of A Microorganism
EP3810805A1Method For Detection And Quantification Of Genetic Alterations
WO2020005159A1Method For Detection And Quantification Of Genetic Alterations
WO2022025824A1Methods For Detecting Rna Viruses
WO2022025825A1Methods And Kits For Determining Integrity Of Viral Rna
WO2022025826A1Method Of Sample Collection
WO2022025823A1Methods And Kits For Detecting And Sequencing Rna Viruses
WO2022035382A1Automated Sample Pre-Processing System And Method
MYPI2018000933A0Detection And Quantification Of Target Nucleic Acid Sequence Of A Microorganism
SG11201707067UAA Multigene Assay
SG11201602019XAMultigene Assay For Prognosis Of Renal Cancer
SG11201805115PADetection And Quantification Of Target Nucleic Acid Sequence Of A Microorganism
SG11202012687SAMethod For Detection And Quantification Of Genetic Alterations
SG10202108293WAMethod Of Sample Collection
SG10202007826SAMethod For Automated Workflow For Saliva And Sputum Sample Solubilization, Pooling And Pre-Concentration To Enhance Molecular Testing Of Nucleic Acid Viruses
SG10202007267SANon-Invasive Naso-Oropharyngeal (Nop) Saliva Collection And Transport In Stabilization Fluid To Enhance Molecular Diagnostic Testing Of Rna Viruses
SG10202007270PAMethod Of Sensitive Detection And Sequencing Of Rna Viruses
DE602014058377T2Multigentest For The Forecast Of Renal Cancer
DE602016039994T2Multi-Assay
DE602016058601T2Detection And Quantification Of A Target Nucleic Acid Sequence Of A Microorganism
HK1248771AA Multigene Assay
HK1263315ADetection And Quantification Of Target Nucleic Acid Sequence Of A Microorganism
HK40045286AMethod For Detection And Quantification Of Genetic Alterations

What are Lucence key innovation segments?

What Technologies are Covered by Lucence?

The chart below distributes patents filed by Lucence in different countries on the basis of the technology protected in patents. It also represents the markets where Lucence thinks it’s important to protect particular technology inventions.

R&D Focus: How has Lucence search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Lucence?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.